Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.51 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PDE5A | O76074 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL279524 | 0.96 | SIGMAR1 (0.51) | SIGMAR1DHFRL3MBTL1PDE5ACYP1A2 | |
| SCHEMBL12048414 | 0.95 | SIGMAR1 (0.48) | SIGMAR1DHFRL3MBTL1PDE5ACYP1A2 | |
| SCHEMBL13721628 | 0.95 | SIGMAR1 (0.50) | SIGMAR1DHFRL3MBTL1PDE5ACYP1A2 | |
| SCHEMBL12047907 | 0.92 | SIGMAR1 (0.45) | SIGMAR1DHFRL3MBTL1PDE5ACYP1A2 | |
| SCHEMBL12048421 | 0.92 | SIGMAR1 (0.45) | SIGMAR1DHFRL3MBTL1PDE5ACYP1A2 | |
| SCHEMBL12048286 | 0.92 | SIGMAR1 (0.48) | SIGMAR1DHFRL3MBTL1PDE5ACYP1A2 | |
| SCHEMBL12047767 | 0.91 | SIGMAR1 (0.50) | SIGMAR1DHFRL3MBTL1PDE5A | |
| SCHEMBL12047903 | 0.91 | SIGMAR1 (0.50) | SIGMAR1DHFRL3MBTL1CYP1A2CYP2D6 | |
| SCHEMBL12048291 | 0.90 | SIGMAR1 (0.47) | SIGMAR1DHFRL3MBTL1PDE5ASLC6A2 | |
| SCHEMBL12047986 | 0.90 | SIGMAR1 (0.47) | SIGMAR1DHFRL3MBTL1PDE5ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9502662-B2 | Compound for an organic optoelectronic device, organic light-emitting element comprising same, and display device comprising the organic light-emitting element | CHEIL INDUSTRIES, INC. (KR) | 2016-11-22 | — | — | US | disclosed |
| US-9502662-B2 | Compound for an organic optoelectronic device, organic light-emitting element comprising same, and display device comprising the organic light-emitting element | CHEIL INDUSTRIES, INC. (KR) | 2016-11-22 | — | — | US | disclosed |
| US-20150263291-A1 | COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, AND DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING ELEMENT | CHEIL INDUSTRIES, INC. (KR) | 2015-09-17 | — | — | US | disclosed |
| US-20150263291-A1 | COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, AND DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING ELEMENT | CHEIL INDUSTRIES, INC. (KR) | 2015-09-17 | — | — | US | disclosed |
| US-9048436-B2 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-02 | — | — | US | disclosed |
| US-9048436-B2 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-02 | — | — | US | disclosed |
| US-8968884-B2 | Compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2015-03-03 | — | — | US | disclosed |
| US-8968884-B2 | Compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2015-03-03 | — | — | US | disclosed |
| EP-1976838-B1 | OXADIAZOLE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE USING THE OXADIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2015-02-25 | — | — | EP | disclosed |
| US-20140299822-A1 | Oxadiazole Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Oxadiazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-10-09 | — | — | US | disclosed |
| US-20090045721-A1 | Compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2009-02-19 | — | — | US | disclosed |
| US-20080093983-A1 | Compound and Organic Light Emitting Device Using the Same | LG CHEM. LTD. (KR) | 2008-04-24 | — | — | US | disclosed |
| US-20080093983-A1 | Compound and Organic Light Emitting Device Using the Same | LG CHEM. LTD. (KR) | 2008-04-24 | — | — | US | disclosed |
| US-20080093982-A1 | Compound and Organic Light Emitting Device Using the Same | LG CHEM, LTD. (KR) | 2008-04-24 | — | — | US | disclosed |
| US-20080093982-A1 | Compound and Organic Light Emitting Device Using the Same | LG CHEM, LTD. (KR) | 2008-04-24 | — | — | US | disclosed |
| US-20070247059-A1 | Compound and Organic Light Emitting Device Using the Same | LG CHEM, LTD. (KR) | 2007-10-25 | — | — | US | disclosed |
| US-20070247059-A1 | Compound and Organic Light Emitting Device Using the Same | LG CHEM, LTD. (KR) | 2007-10-25 | — | — | US | disclosed |
| WO-2007074893-A1 | OXADIAZOLE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE USING THE OXADIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-07-05 | — | — | WO | disclosed |
| US-20070149784-A1 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-06-28 | — | — | US | disclosed |
| US-20070149784-A1 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149784-A1 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | OXA1L, ADRA1D, CRY1 | SIGMAR1 1454/4885DHFR 3897/4885L3MBTL1 909/4885 |
| US-20150263291-A1 | COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME, AND DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING ELEMENT | AOX1, OCIAD1, AOC2 | SIGMAR1 1977/4885DHFR 1708/4885L3MBTL1 1274/4885 |
| US-20070247059-A1 | Compound and Organic Light Emitting Device Using the Same | PPOX, CRY1, CRY2 | SIGMAR1 4092/4885DHFR 1451/4885L3MBTL1 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.